Company’s 36-month beta value is 1.33.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HCAT is 56.16M, and currently, short sellers hold a 3.13% ratio of that floaft. The average trading volume of HCAT on May 10, 2024 was 660.48K shares.
HCAT) stock’s latest price update
The stock price of Health Catalyst Inc (NASDAQ: HCAT) has surged by 0.30 when compared to previous closing price of 6.65, but the company has seen a 1.99% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-05-09 that The headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCAT’s Market Performance
HCAT’s stock has risen by 1.99% in the past week, with a monthly rise of 7.06% and a quarterly drop of -31.24%. The volatility ratio for the week is 6.17% while the volatility levels for the last 30 days are 5.88% for Health Catalyst Inc The simple moving average for the last 20 days is 9.63% for HCAT stock, with a simple moving average of -26.48% for the last 200 days.
Analysts’ Opinion of HCAT
Evercore ISI, on the other hand, stated in their research note that they expect to see HCAT reach a price target of $11. The rating they have provided for HCAT stocks is “Outperform” according to the report published on January 03rd, 2024.
Barclays gave a rating of “Overweight” to HCAT, setting the target price at $14 in the report published on January 03rd of the current year.
HCAT Trading at -5.59% from the 50-Day Moving Average
After a stumble in the market that brought HCAT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -53.58% of loss for the given period.
Volatility was left at 5.88%, however, over the last 30 days, the volatility rate increased by 6.17%, as shares surge +4.22% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.26% lower at present.
During the last 5 trading sessions, HCAT rose by +1.99%, which changed the moving average for the period of 200-days by -48.73% in comparison to the 20-day moving average, which settled at $6.10. In addition, Health Catalyst Inc saw -27.97% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HCAT starting from Llewelyn Linda, who sale 2,005 shares at the price of $6.11 back on Apr 15 ’24. After this action, Llewelyn Linda now owns 126,226 shares of Health Catalyst Inc, valued at $12,251 using the latest closing price.
Llewelyn Linda, the Chief People Officer of Health Catalyst Inc, sale 2,005 shares at $7.80 during a trade that took place back on Mar 15 ’24, which means that Llewelyn Linda is holding 128,231 shares at $15,648 based on the most recent closing price.
Stock Fundamentals for HCAT
Current profitability levels for the company are sitting at:
- -0.39 for the present operating margin
- 0.42 for the gross margin
The net margin for Health Catalyst Inc stands at -0.4. The total capital return value is set at -0.19. Equity return is now at value -29.84, with -16.25 for asset returns.
Based on Health Catalyst Inc (HCAT), the company’s capital structure generated 0.39 points at debt to capital in total, while cash flow to debt ratio is standing at -0.14. The debt to equity ratio resting at 0.63. The interest coverage ratio of the stock is -13.9.
Currently, EBITDA for the company is -40.55 million with net debt to EBITDA at -1.97. When we switch over and look at the enterprise to sales, we see a ratio of 1.81. The receivables turnover for the company is 4.84for trailing twelve months and the total asset turnover is 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.39.
Conclusion
In a nutshell, Health Catalyst Inc (HCAT) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
